1. Cell Cycle/DNA Damage
  2. IRE1
  3. MKC8866

MKC8866  (Synonyms: Orin1001)

目录号: HY-104040 纯度: 99.95%
COA 产品使用指南

MKC8866 是一种水杨醛类似物,有效的选择性 IRE1 RNase 抑制剂,在体外的 IC50 为 0.29 μM。 MKC8866 强烈抑制 Dithiothreitol 诱导的 XBP1s 表达,EC50 为 0.52 μM。MKC8866 抑制无应激 RPMI 8226 细胞,IC50 为 0.14 μM。 MKC8866 抑制乳腺癌细胞中的 IRE1 RNase 导致促肿瘤发生因子减少,同时也能抑制前列腺癌 (PCa) 肿瘤的生长。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

MKC8866 Chemical Structure

MKC8866 Chemical Structure

CAS No. : 1338934-59-0

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
10 mM * 1 mL in DMSO ¥2640
In-stock
1 mg ¥1090
In-stock
5 mg ¥2400
In-stock
10 mg ¥3720
In-stock
25 mg 现货 询价
50 mg 现货 询价
100 mg 现货 询价
200 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

Customer Review

    MKC8866 purchased from MCE. Usage Cited in: Cancer Lett. 2020 Oct 10;490:76-88.  [Abstract]

    RH30 and RD cells are treated with MKC8866 (20 μM) and/or AMGEN44 (2 μM) for 72 hours and Western blot confirmes IRE1 and PERK signalling inhibition. In cells treated with AMGEN44 alone or in combination with MKC8866, PERK phosphorylation is reduced and p-eIF2α protein levels are diminished. In cells treated with MKC8866 alone or in combination with AMGEN44, XBP1s protein levels are completely abolished.
    • 生物活性

    • 纯度 & 产品资料

    • 参考文献

    生物活性

    MKC8866, a salicylaldehyde analog, is a potent, selective IRE1 RNase inhibitor with an IC50 of 0.29 μM in human vitro. MKC8866 strongly inhibits Dithiothreitol-induced X-box-binding protein 1-spliced (XBP1s) expression with an EC50 of 0.52 μM and unstresses RPMI 8226 cells with an IC50 of 0.14 μM[1]. MKC8866 inhibits IRE1 RNase in breast cancer cells leading to the decreased production of pro-tumorigenic factors and it can inhibits prostate cancer (PCa) tumor growth[2].

    IC50 & Target

    IC50: 0.29 μM (IRE1 RNase)[1]

    体外研究
    (In Vitro)

    MKC8866 (20?μM; 6 days) decreases proliferation of all breast cancer cell lines[2].
    ? MKC8866 (20 μM; 48 hours) reduces the number of cells entering S phase[2].
    ? MKC8866 (0.2-10 μM; 3 days) suppresses the viability of all four cell lines in a dose-dependent manner under normal conditions, with the most robust effect in LNCaP cells[1].
    ? MKC8866 (20 μM; 72?hours) is sufficient to completely block NSC 125973-induced expression of XBP1s [1].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Cell Proliferation Assay[2]

    Cell Line: MCF7, SKBR3, MDA-MB-231 and MCF10A cells
    Concentration: 20 μM
    Incubation Time: For 6 days
    Result: Decreased proliferation of all breast cancer cell lines.

    Cell Cycle Analysis[2]

    Cell Line: MDA-MB-231, MCF7 and SKBR3 cells
    Concentration: 20 μM
    Incubation Time: 48 hours
    Result: Reduced the number of cells entering S phase.

    Cell Cycle Analysis[1]

    Cell Line: LNCaP, VCaP, 22Rv1 and C4-2B cells
    Concentration: 0.2, 0.5, 1, 5, 10 μM
    Incubation Time: 3 days
    Result: Suppressed the viability of all four cell lines in a dose-dependent manner.

    Cell Cycle Analysis[2]

    Cell Line: MDA-MB-231 cells
    Concentration: 20 μM
    Incubation Time: 72  hours
    Result: Completely blocked NSC 125973-induced expression of XBP1s.
    体内研究
    (In Vivo)

    MKC8866 (oral ; 300 mg/kg; for 28 days) reduces tumor regrowth post-NSC 125973 withdrawal[1].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: Female athymic nude mice with MDA-MB-231 tumor[1]
    Dosage: 300 mg/kg
    Administration: Oral; for 28 days
    Result: Reduced tumor regrowth post-NSC 125973 withdrawal.
    Clinical Trial
    分子量

    361.35

    Formula

    C18H19NO7

    CAS 号
    性状

    固体

    颜色

    Light yellow to yellow

    运输条件

    Room temperature in continental US; may vary elsewhere.

    储存方式
    Powder -20°C 3 years
    4°C 2 years
    In solvent -80°C 6 months
    -20°C 1 month
    溶解性数据
    细胞实验: 

    DMSO 中的溶解度 : 6.67 mg/mL (18.46 mM; 超声助溶 (<60°C); 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

    配制储备液
    浓度 溶剂体积 质量 1 mg 5 mg 10 mg
    1 mM 2.7674 mL 13.8370 mL 27.6740 mL
    5 mM 0.5535 mL 2.7674 mL 5.5348 mL
    查看完整储备液配制表

    * 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
    储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

    • 摩尔计算器

    • 稀释计算器

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    质量
    =
    浓度
    ×
    体积
    ×
    分子量 *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    浓度 (start)

    C1

    ×
    体积 (start)

    V1

    =
    浓度 (final)

    C2

    ×
    体积 (final)

    V2

    动物溶解方案计算器
    请输入动物实验的基本信息:

    给药剂量

    mg/kg

    动物的平均体重

    g

    每只动物的给药体积

    μL

    动物数量

    由于实验过程有损耗,建议您多配一只动物的量
    计算结果
    工作液所需浓度 : mg/mL
    纯度 & 产品资料

    纯度: 99.95%

    参考文献

    完整储备液配制表

    * 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
    储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

    可选溶剂 浓度 溶剂体积 质量 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 2.7674 mL 13.8370 mL 27.6740 mL 69.1850 mL
    5 mM 0.5535 mL 2.7674 mL 5.5348 mL 13.8370 mL
    10 mM 0.2767 mL 1.3837 mL 2.7674 mL 6.9185 mL
    15 mM 0.1845 mL 0.9225 mL 1.8449 mL 4.6123 mL
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    您最近查看的产品:

    Your information is safe with us. * Required Fields.

       产品名称:

     

    * 需求量:

    * 客户姓名:

     

    * Email:

    * 电话:

     

    * 公司或机构名称:

       留言给我们:

    Bulk Inquiry

    Inquiry Information

    产品名称:
    MKC8866
    目录号:
    HY-104040
    需求量: